The efficacy of Eli Lilly's new, still-in-development GLP-1 drug is gaining attention, but don't forget its older GLP-1 drugs ...

Although there are drawbacks to taking GLP-1 drugs (such as muscle loss), they are viewed as a miracle drug by many who have ...

The UC Davis Innovation Institute for Food and Health recently hosted scientists, physicians and industry experts to discuss how drugs based on GLP-1 are transforming treatment for obesity, diabetes ...

There is no shortage of headlines about GLP-1 medications. Originally developed to manage blood sugar levels, these medications are now widely known for promoting weight loss. Alongside their rapid ...

GLP-1 has become a popular buzzword in the weight-loss community — but now some are touting "GLP-3s," claiming they are taking obesity medications to the next level. GLP-1 (glucagon-like peptide-1) ...

The medical device market is expected to grow to almost $800 billion by 2030. Here's a list of the year's best opportunities. The United States has a $115.5 billion trade deficit in pharmaceutical ...

Proprietary Semaglutide + Tirzepatide Dual-Peptide Formulation Now Available Exclusively Through the Tru2u.health PlatformLake Oswego, Portland--(Newsfile Corp. - May 6, 2026) - Functional Brands Inc.

GLP-1 usage is on the rise, and researchers are looking for other health benefits associated with the drug, including its effects on bladder health. But as GLP-1s rise in popularity, so do nicknames ...

GLP-1 medications treat type 2 diabetes and obesity by mimicking a hormone that helps manage blood sugar. A balanced diet can improve how well these medications work. The best foods to eat while on ...

The use of weight-loss injections has sky-rocketed, sometimes leading to unique or strange side effects. The most recent concern? Hair loss. Here’s a look at the facts. ByTanya Akim, Contributor.

Add Yahoo as a preferred source to see more of our stories on Google. Dominic Garcia reports. Tom Brady, Robert Kraft respond on Bill Belichick's reported HOF snub: 'If he's not a first-ballot Hall of ...